Interestingly, (+)-strebloside was found to show more potent cancer cell cytotoxicity and lower toxicity in mice when compared with digoxin, and it targets NKA, NF-κB, and p53, to mediate its antitumor potential [9,11]. Here, TAC1 is linked to cancer.